Fumonisin B2-13C34, CAS 1217481-36-1

Product Description: Fumonisin B2-13C34 is the 13C labeled Fumonisin B2 (HY-N6723)[1]. Fumonisin B2, a mycotoxin produced by Fusarium moniliforme in various grains, is a potent inhibitor of sphingosine N-acyltransferase (ceramide synthase) and disrupts de novo sphingolipid biosynthesis[2][3].

Applications: COVID-19-immunoregulation

Formula: 13C34H59NO14

References: [1]Henry MH, et al. The toxicity of fumonisin B1, B2, and B3, individually and in combination, in chicken embryos. Poult Sci. 2001 Apr;80(4):401-7./[2]Wei T, et al. Natural occurrence of fumonisins B1 and B2 in corn in four provinces of China. Food Addit Contam Part B Surveill. 2013;6(4):270-4./[3]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-220.

CAS Number: 1217481-36-1

Molecular Weight: 739.58

Research Area: Infection

Solubility: 10 mM in DMSO

Target: Isotope-Labeled Compounds

• Artikelnummer: MEXHY-N6723S-12UG
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-N6723S-12UG
• Verpackungseinheit: 12 ug(13.52 μM * 1.2 mL in Acetonitrile)
• Mengeneinheit: STK